Diligence memo · auto-generated · as of July 3, 2026
Cero Therapeutics Holdings, Inc.
Cero Therapeutics Holdings, Inc. looks fair against its niche peers and is active on financing cadence.
Businessfiled
Cero Therapeutics Holdings, Inc. operates in Pharmaceuticals, based in SOUTH SAN FRANCISCO.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Cero Therapeutics Holdings, Inc. has raised $16M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $10M on 2024-02-14.
Most recent recorded round closed around 2025-04-22.
Valuation (modeled)modeled
Provath models Cero Therapeutics Holdings, Inc. at approximately $18M (range $5.7M–$32M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.11× the median modeled value of Series A Pharmaceuticals companies in 2025–2027 (37 peers) — value vs value, same stage and era. Within the normal band (111% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 7 months.
Last raise 14 mo ago; this sector typically re-raises about every 13 months.
Raising on or ahead of the sector's normal rhythm.
The last round stepped up 4.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 63% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 26% of those peers.
Closest niche peers: Incannex Healthcare Inc., Retension Pharmaceuticals, Inc., Eikonoklastes Therapeutics, Inc., Phoenicis Therapeutics, Inc., Pharmaceutical Resource Technology, Inc..
Peoplefiled
16 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.